VEGFA and cancer: AI-Nedawi et al. demonstrated that the transfer of the oncogenic constitutively active epidermal growth factor receptor variant III (EGFRvIII) via EVs can transmit oncogenic activity among cancer cells and active vascular endothelial growth factor (VEGF) signaling in endothelial cells[11].